These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27318682)

  • 21. Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges.
    Ahmad K; Lee EJ; Shaikh S; Kumar A; Rao KM; Park SY; Jin JO; Han SS; Choi I
    Semin Cancer Biol; 2021 Feb; 69():325-336. PubMed ID: 31454671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.
    Cooper J; Giancotti FG
    Cancer Cell; 2019 Mar; 35(3):347-367. PubMed ID: 30889378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.
    Paulhe F; Manenti S; Ysebaert L; Betous R; Sultan P; Racaud-Sultan C
    Curr Pharm Des; 2005; 11(16):2119-34. PubMed ID: 15974963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrins in cell adhesion and signaling.
    Akiyama SK
    Hum Cell; 1996 Sep; 9(3):181-6. PubMed ID: 9183647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrins: signaling, disease, and therapy.
    Huveneers S; Truong H; Danen HJ
    Int J Radiat Biol; 2007; 83(11-12):743-51. PubMed ID: 17852562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer.
    Aksorn N; Chanvorachote P
    Anticancer Res; 2019 Feb; 39(2):541-548. PubMed ID: 30711928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.
    Sun Y; Nelson PS
    Clin Cancer Res; 2012 Aug; 18(15):4019-25. PubMed ID: 22619305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrins regulate stemness in solid tumor: an emerging therapeutic target.
    Xiong J; Yan L; Zou C; Wang K; Chen M; Xu B; Zhou Z; Zhang D
    J Hematol Oncol; 2021 Oct; 14(1):177. PubMed ID: 34715893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.
    Seguin L; Desgrosellier JS; Weis SM; Cheresh DA
    Trends Cell Biol; 2015 Apr; 25(4):234-40. PubMed ID: 25572304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrins as therapeutic targets.
    Goodman SL; Picard M
    Trends Pharmacol Sci; 2012 Jul; 33(7):405-12. PubMed ID: 22633092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin bi-directional signaling across the plasma membrane.
    Hu P; Luo BH
    J Cell Physiol; 2013 Feb; 228(2):306-12. PubMed ID: 22767296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Targeting and role of α4β7 integrin in the pathophysiology of IBD and HIV infection].
    Girard A; Rochereau N; Roblin X; Genin C; Paul S
    Med Sci (Paris); 2015 Oct; 31(10):895-903. PubMed ID: 26481029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin-mediated adhesion and stem-cell-niche interactions.
    Ellis SJ; Tanentzapf G
    Cell Tissue Res; 2010 Jan; 339(1):121-30. PubMed ID: 19588168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cells.
    Morad SA; Bridges LC; Almeida Larrea AD; Mayen AL; MacDougall MR; Davis TS; Kester M; Cabot MC
    Cancer Lett; 2016 Jul; 376(2):199-204. PubMed ID: 27045476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell Adhesion Molecules: Therapeutic Targets for Inhibition of Inflammatory States.
    Allen S; Moran N
    Semin Thromb Hemost; 2015 Sep; 41(6):563-71. PubMed ID: 26322694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase.
    Yasuda M; Tanaka Y; Tamura M; Fujii K; Sugaya M; So T; Takenoyama M; Yasumoto K
    Cancer Res; 2001 Mar; 61(5):2022-30. PubMed ID: 11280762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Integrins, cell response to anti-tumor agents and chemoresistance].
    Maubant S; Staedel C; Gauduchon P
    Bull Cancer; 2002 Nov; 89(11):923-34. PubMed ID: 12495880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interplay between Src and integrins in normal and tumor biology.
    Playford MP; Schaller MD
    Oncogene; 2004 Oct; 23(48):7928-46. PubMed ID: 15489911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.